13F Pro quality score
Rank #2,782 of 2,925
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
Reported revenue, net income and operating margin by fiscal year, from NATURAL HEALTH TRENDS CORP's annual filings on SEC EDGAR.
| Period | Form | Revenue | Net income | Op. marginOperating margin |
|---|---|---|---|---|
| FY 2025 | 10-K | $39.8M | $-882.0K | -4.5% |
| FY 2024 | 10-K | $43.0M | $572.0K | -3.0% |
| FY 2023 | 10-K | $43.9M | $568.0K | -3.8% |
| FY 2022 | 10-K | $49.1M | $313.0K | -0.5% |
| FY 2021 | 10-K | $60.0M | $1.1M | 2.6% |
| FY 2020 | 10-K | $62.1M | $843.0K | 1.1% |
Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.
NATURAL HEALTH TRENDS CORP (NHTC) stock profile, AI quality score, and SEC EDGAR financial data, a Consumer Staples sector company. 13F Pro's AI-powered ranking engine scores NHTC at 17.8/100 on a composite quality score built from its SEC filings, placing it at rank #2,782 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include earnings quality (1.2) and revenue scale (7.0), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), NATURAL HEALTH TRENDS CORP reports quarterly revenue of $7.6M, net income of $-451.0K, an operating margin of -8.5%. Top institutional holders of NHTC by reported 13-F value include RENAISSANCE TECHNOLOGIES, BlackRock, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. NHTC trades on the Nasdaq exchange and files with the SEC under CIK 912061. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NHTC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NATURAL HEALTH TRENDS CORP directly from SEC EDGAR.
Financials through the period ended SEC EDGAR: CIK 912061 →